320. Inherited glycosylphosphatidylinositol deficiency Clinical trials / Disease details
Clinical trials : 3 / Drugs : 2 - (DrugBank : 2) / Drug target gene : 0 - Drug target pathway : 0
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JPRN-UMIN000024185 | 2014/07/31 | 27/09/2016 | Prospective non- control non- randomized, open-label study about efficacy of vitamin B6 for inherited GPI deficiency | Prospective non- control non- randomized, open-label study about efficacy of vitamin B6 for inherited GPI deficiency - Interventional study of vitamin B6 for inherited GPI deficiency | Inherited GPI deficiency | Initial dose: pyridoxine 10-15 mg/kg/day 1-2 weeks after the initiation, the dose is increased to maintenance dose, if there is no adverse effect. Maintenance dose: pyridoxine 20-30 mg/kg/day We prescribe pyridoxine for a year. | The Graduate School of Medicine, Osaka University | Department of Child Neurology, Tottori University Hospital | Complete: follow-up complete | Not applicable | Not applicable | Male and Female | 15 | Not selected | Japan |